探讨婴幼儿血管瘤与高钾血症的关系
摘要
关键词
全文:
PDF参考
[1]刘小烨,齐蔓莉.婴幼儿血管瘤发病机制研究进展[J].中国麻风皮肤病杂志,2023,39(1):61-64.
[2]儿童临床常用生化检验项目参考区间.中华人民共和国卫生行业标准WS/T 780-2021[S].
[3]Pavlakovic H, Kietz S, Lauerer P, et al. Hyperkalemia complicating propranolol treatment of an infantile hemangioma[J].Pediatrics.2010,126(6):e1589-e1593.
[4]Belen B, Oguz A, Okur A, et al. A complication to be aware of: hyperkalaemia following propranolol therapy for an infant with intestinal haemangiomatozis[J]. BMJ Case Rep. 2014,2014.
[5]Ji Y, Chen S, Wang Q, et al. Intolerable side effects during propranolol therapy for infantile hemangioma: frequency, risk factors and management[J]. Sci Rep.2018,8(1):4264.
[6]Al-Rwebah H, Alkhodair R, Al-Khenaizan S. Propranolol-induced hyperkalemia in the management of infantile hemangioma[J].JAAD Case Rep.2020,6(4): 359-361.
[7]Dreyfus I,Maza A,Mazereeuw-Hautier J.[What's new about infantile hemangiomas?][J].ARCHIVES DE PEDIATRIE.2013;20(7):809-16.
[8] Cavalli R, Buffon R B, de Souza M, et al. Tumor lysis syndrome after propranolol therapy in ulcerative infantile hemangioma: rare complication or incidental finding?[J]. Dermatology.2012,224(2):106-109.
[9]Leaute Labreze C, de la Roque ED, Hubiche T, et al. Propranolol for severe hemangiomas of infancy[J]. N Engl J Med 2008;358:2649–51.
[10]Erbay A, Sarialioglu F, Malbora B, et al. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants[J]. Turk J Pediatr 2010;52:450–6.
[11]Palmer Biff F,Clegg Deborah J.Extrarenal Effects of Aldosterone on Potassium Homeostasis[J].Kidney360.2022;3 (3):561-568.
[12]Kupeli S. Use of propranolol for infantile hemangiomas[J]. Pediatr Hematol Oncol 2012;29:293–8.
[13]Storch CH, Hoeger PH. Propranolol for infantile hemangiomas: insights into the molecular mechanisms of action[J].Br J Dermatol 2010;163:269–74.
(0 摘要 Views, 0 PDF Downloads)
Refbacks
- 当前没有refback。